OLIGOMERIX
Live / Registered — Registered and renewed (as of 04 Oct 2025)
What this means for you
Registered since 23 Jun 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Jun 2025).
Record
- Serial number
- 85886219
- Registration number
- 4760737
- Mark type
- Stylized text
- Filed
- 26 Mar 2013
- Published for opposition
- 11 Nov 2014
- Registered
- 23 Jun 2015
- Next maintenance due
- 23 Jun 2025
- Attorney of record
- Nicole K. McLaughlin
Goods and services
- Class 001 — Chemicals: Chemical products and compositions intended for medical research, namely, reagents, chemical entities and compounds; chemical preparations for scientific purposes, chemical reagents or products for laboratory analyses for monitoring, analyzing and identifying diagnostic targets and therapeutic products, and for conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposes, namely, for leading research in connection with pharmaceutical sciences
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of diseases, namely, Alzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; biopharmaceutical products, namely, reagents, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposes, namely, chemicals for diagnosing Alzheimer's disease and other neurodegenerative diseases, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases
- Class 042 — Scientific and technological services: Research and development of pharmaceutical molecules, compounds, inhibitors, antibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology
Owner
- Oligomerix, Inc., White Plains, NY, US
- Oligomerix, Inc., New York, NY, US
- Oligomerix, Inc., New York, NY, US
Prosecution history
- 04 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Oct 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Oct 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jun 2025 — TEAS SECTION 8 & 9 RECEIVED
- 23 Jun 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Jun 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Dec 2021 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jun 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2015 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 May 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 May 2015 — STATEMENT OF USE PROCESSING COMPLETE